Empowering Innovation: Comprehensive Drug Discovery Services
In today’s fast-evolving pharmaceutical landscape, the demand for faster, smarter, and more efficient drug development is at an all-time high. Jubilant Biosys, a globally renowned Contract Research, Development, and Manufacturing Organization (CRDMO), stands at the forefront of scientific innovation with its Comprehensive drug discovery services.
Leveraging deep scientific expertise, cutting-edge technology, and strategic collaboration, Jubilant Biosys helps pharmaceutical and biotech companies expedite their drug discovery journey from early research to clinical development.
End-to-End Drug Discovery Solutions
Jubilant Biosys offers integrated drug discovery services that span the entire discovery pipeline. From target validation and hit identification to lead optimization and candidate nomination, their services are tailored to deliver high-quality outcomes with speed and efficiency. The company works across multiple therapeutic areas including oncology, neuroscience, metabolic disorders, and inflammation.
1. Target Identification and Validation
Utilizing bioinformatics, genomics, and advanced assay platforms, Jubilant Biosys identifies and validates novel drug targets. This forms the foundation for successful drug discovery programs.
2.
Hit Generation and High-Throughput
Screening (HTS)
With access to vast compound libraries and proprietary screening tools, Jubilant conducts high-throughput and fragment-based screening to identify promising chemical starting points.
3.
Hit-to-Lead
and Lead Optimization
Jubilant’s experienced medicinal chemistry team focuses on optimizing hits for potency,selectivity,andpharmacokinetics,turningthemintoviableleadcompounds ready for preclinical evaluation.
4. In Vitro and In Vivo Biology
The biology team offers cell-based and biochemical assays, efficacy testing, and mechanistic studies to support compound profiling and decision-making.
5. DMPK and Toxicology
Jubilant provides robust drug metabolism, pharmacokinetics, and early toxicology studies, ensuring candidate compounds meet safety and efficacy benchmarks before entering clinical phases.
6. Computational Chemistry and Data Sciences
By integrating artificial intelligence (AI), machine learning (ML), and cheminformatics, Jubilant enables data-driven decisions and speeds up the drug design process.
Infrastructure and Scientific Excellence
Jubilant Biosys operates state-of-the-art research facilities in India, staffed with over1,000 scientists,including medicinal chemists,biologists, pharmacologists, and computational experts. Their labs are equipped with advanced instrumentation and automation platforms, ensuring efficient and reproducible research outcomes. The company's commitment to quality, data integrity, and intellectual property (IP) protection has earned the trust of leading pharmaceutical and biotech companies across North America, Europe, and Asia. Jubilant Biosys also operates under GLP and ISO-certified systems, aligning with international regulatory standards.
Flexible Collaboration Models
To suit diverse client needs, Jubilant Biosys offers flexible engagement models including:
• FTE (Full-Time Equivalent)
• FFS (Fee-for-Service)
• Integrated Program-Based Models
• Risk-Sharing Partnerships
These models provide scalable, cost-effective, and transparent solutions that align with both short-term projects and long-term research partnerships.
Conclusion
In a competitive drug development environment, Jubilant Biosys’s drug discovery services offer a powerful advantage. By integrating multidisciplinary expertise,
cutting-edge technologies, and a client-centric approach, Jubilant Biosys transforms scientific ideas into viable drug candidates.
From target to IND (Investigational New Drug), Jubilant is a trusted partner for innovative, efficient, and accelerated drug discovery. Whether you're a biotech startup or a global pharmaceutical company, Jubilant Biosys delivers the strategy, science, and support you need to bring life-changing therapies to market.